node-positive disease who were randomized to receive pembrolizumab 200 mg or placebo every 3 weeks for five cycles plus CRT, followed by pembrolizumab 400 mg or placebo every 6 weeks for 15 cycles.

The opposition to Critical Race Theory (CRT) among many prominent Jewish figures raises an important question: Do these critics oppose CRT as a legal and academic theory, or do they oppose how it ...